Purchase Order 19PCRD26K4323
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a Purchase Order for medical supplies valued at $15,678.00 by the Bureau of Administration on December 12, 2025. The contract is structured as a firm fixed-price award with no set-aside designation and will be performed in Lake Mary, Florida, with an ultimate completion date of January 10, 2026. Abbott Rapid DX specializes in point-of-care testing devices and diagnostic supplies, including COVID-19 antigen...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a purchase order award from the Bureau of Administration valued at $11,500.00 with a firm fixed price contract type. The award, dated July 31, 2025, has an ultimate completion date of July 31, 2025 and involves part number adjustments. The contract was awarded without a set-aside designation, indicating open competition. The place of performance is located in Lockhart, Florida. Based on Abbott Rapid DX North...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a firm fixed-price purchase order valued at $11,896.50 for medical supplies by the Bureau of Administration on February 5, 2026, with an ultimate completion date of March 6, 2026. The contract will be performed in Lake Mary, Florida. This award reflects no set-aside designation and was competed on a full and open basis. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $12,720.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on October 15, 2025, with an ultimate completion date of October 21, 2025. The contract, which carries no set-aside designation and indicates open competition, is for a kit identification, now strip A2 qualification detector mobile/mobile laboratory test. Performance will occur in...
- This is a federal contract award to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by a civilian federal agency, the Bureau of Administration. The contract is for the provision of medical supplies, specifically COVID-19 diagnostic products including rapid antigen tests, in vitro diagnostics, and molecular testing platforms. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $13,066.00 and an ultimate completion date of June 15, 2024. The contract...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $3,600.00 for COVID-19 viral test kits containing 24 tests. The contract, issued on November 14, 2025, with an ultimate completion date of November 25, 2025, utilizes a fixed-price structure with economic price adjustment provisions. The award was made without a set-aside designation on a full and open competitive basis by the Defense Logistics Agency Medical Supply Chain, a...
- This is a $16,875.00 firm-fixed price purchase order contract awarded to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by the Bureau of Administration, a civilian federal agency. The contract is for the delivery of medical supplies, with a completion date of January 12, 2024. It does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to various government agencies,...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, was awarded a $1,344.00 delivery order contract on August 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for diagnostic testing supplies and equipment. The contract, designated as a fixed-price agreement with economic price adjustment, calls for delivery of ID NOW Strep A Qualification Detection Mobile Lab Test kits to Lockhart, Florida, with an ultimate completion date of August 19, 2025. This delivery...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $2,400 delivery order (Contract No. 4569814561) for COVID-19 test kits on October 24, 2025, with an ultimate completion date of November 4, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and is performed in Lockhart, Florida. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain, which is a defense-oriented federal agency...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract, valued at $12,060.60, is for the delivery of medical supplies. The period of performance runs through February 1, 2024. This award does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, in vitro...
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a firm fixed-price purchase order valued at $11,896.50 by the Bureau of Administration for medical supplies. The contract, with an ultimate completion date of March 6, 2026, was awarded on February 5, 2026, with no set-aside designation. Performance will occur in Lake Mary, Florida. Abbott Rapid DX specializes in point-of-care diagnostic testing devices and medical supplies, with a particular focus on rapid diagnostic platforms and testing solutions that support federal healthcare operations. Abbott Rapid DX North America LLC maintains an established presence within federal healthcare procurement through extensive contracts with the Department of Veterans Affairs, Defense Logistics Agency, and other civilian agencies. The company's product portfolio includes rapid diagnostic tests, analyzers, reagents, and clinical testing consumables. This purchase order represents a continuation of the company's ongoing supply relationship with federal agencies, supporting the Bureau of Administration's medical supply requirements through a straightforward commercial procurement mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 2/5/26 |